See the impact of ENTYVIO (vedolizumab) in reducing symptoms and achieving remission for ulcerative colitis. See Safety and Prescribing Information.

ENTYVIO® dosing and administration for IV infusion and subcutaneous injection. Find infusion schedule, storage, and injection site information.

Entyvio is a biologic medicine used to treat moderate to severe ulcerative colitis and Crohn’s disease in people who have failed or cannot tolerate other treatments.

Entyvio can be given as a subcutaneous injection for maintenance treatment using Entyvio Pens or prefilled syringes, or can be administered as an intravenous infusion for both induction and …

Entyvio infusion is a treatment option for individuals suffering from inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. If you have been recommended Entyvio …

Entyvio is a brand-name drug prescribed for ulcerative colitis and Crohn’s disease. The medication is available as an IV infusion and subcutaneous injection.

ENTYVIO for ulcerative colitis and Crohn’s disease is prescribed by a doctor along with a referral to get infusion treatments. Once you have a prescription, and doctor’s referral, you can choose …

Vedolizumab - also known as Entyvio - is a biological medication approved for use by adults with moderate to severe Crohn's disease or ulcerative colitis.

The dose of Entyvio is the same for Crohn’s disease and ulcerative colitis. You’ll receive the first two doses, 300 milligrams (mg), of Entyvio as IV infusions at week 0 and week 2 of treatment.

ENTYVIO is a biologic treatment for moderate to severe Crohn's disease (CD) or ulcerative colitis (UC). See Safety and Prescribing Information.